“An Avidity-based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy” paper accepted for publication
Our paper entitled “An Avidity-based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy” has been accepted for publication by Nano Letters. The authors are Jiyoon, Ashita, Mari, Woo-jin, Mike, Kara, Luke, Elizabeth, Dr. Wheeler, and Dr. Hong. Congratulations!